Healthcare provider profile · identity verified

Jasdeep Dhami, M.D.

Family Practice · TRACY, CA · NPI 1770978579

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	405	122
Amlodipine Besylate	Amlodipine Besylate	232	65
Omeprazole	Omeprazole	197	61
Levothyroxine Sodium	Levothyroxine Sodium	190	55
Metformin Hcl	Metformin Hcl	160	52
Lisinopril	Lisinopril	143	41
Pantoprazole Sodium	Pantoprazole Sodium	142	34
Rosuvastatin Calcium	Rosuvastatin Calcium	140	41
Metoprolol Succinate	Metoprolol Succinate	139	40
Gabapentin	Gabapentin	128	45
Losartan Potassium	Losartan Potassium	125	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	118	29
Ozempic	Semaglutide	114	17
Duloxetine Hcl	Duloxetine Hcl	105	23
Meloxicam	Meloxicam	105	41
Fluticasone Propionate	Fluticasone Propionate	102	40
Montelukast Sodium	Montelukast Sodium	101	27
Simvastatin	Simvastatin	100	28
Albuterol Sulfate Hfa	Albuterol Sulfate	88	35
Famotidine	Famotidine	87	27
Metoprolol Tartrate	Metoprolol Tartrate	87	27
Furosemide	Furosemide	78	24
Alprazolam	Alprazolam	69	suppressed
Metformin Hcl Er	Metformin Hcl	69	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	24
Carvedilol	Carvedilol	66	18
Trazodone Hcl	Trazodone Hcl	66	23
Zolpidem Tartrate	Zolpidem Tartrate	66	11
Allopurinol	Allopurinol	63	17
Lorazepam	Lorazepam	59	15
Alendronate Sodium	Alendronate Sodium	57	19
Tamsulosin Hcl	Tamsulosin Hcl	57	20
Ezetimibe	Ezetimibe	56	15
Jardiance	Empagliflozin	55	21
Hydrochlorothiazide	Hydrochlorothiazide	53	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Baclofen	Baclofen	49	13
Tramadol Hcl	Tramadol Hcl	48	12
Sertraline Hcl	Sertraline Hcl	47	16
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	39
Prednisone	Prednisone	41	16
Potassium Chloride	Potassium Chloride	39	suppressed
Topiramate	Topiramate	39	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Spironolactone	Spironolactone	38	suppressed
Cephalexin	Cephalexin	36	27
Farxiga	Dapagliflozin Propanediol	35	11
Sucralfate	Sucralfate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Xarelto	Rivaroxaban	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	15
Irbesartan	Irbesartan	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Eliquis	Apixaban	30	suppressed
Hydrocortisone	Hydrocortisone	27	14
Mirtazapine	Mirtazapine	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Fluconazole	Fluconazole	21	12
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Atenolol	Atenolol	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Azithromycin	Azithromycin	18	17
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Multaq	Dronedarone Hcl	18	suppressed
Glipizide	Glipizide	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Digoxin	Digoxin	16	suppressed
Naloxone Hcl	Naloxone Hcl	16	12
Trulicity	Dulaglutide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ciclopirox	Ciclopirox Olamine	15	suppressed
Finasteride	Finasteride	15	suppressed
Ondansetron Odt	Ondansetron	15	13
Rybelsus	Semaglutide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Naproxen	Naproxen	14	suppressed
Nystop	Nystatin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dupixent Syringe	Dupilumab	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Enulose	Lactulose	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error